期刊
CLINICAL INFECTIOUS DISEASES
卷 34, 期 8, 页码 1129-1136出版社
UNIV CHICAGO PRESS
DOI: 10.1086/339542
关键词
-
资金
- NIAID NIH HHS [AI-27663, AI-27660, 2 U01 AI-38855, 5 UO1 AI-27658] Funding Source: Medline
- NIEHS NIH HHS [T32 ES07142-18] Funding Source: Medline
- NIMH NIH HHS [P30 MH59037] Funding Source: Medline
High-level adherence to regimens of combination antiretroviral therapy and prophylactic medications for opportunistic infections (OIs) is crucial to their success. However, little is known about the association between adherence to these life-sustaining therapies and such clinical outcomes as progression of acquired immune deficiency syndrome (AIDS) or development of OIs. We assessed adherence to regimens of antiretroviral and Mycobacterium avium complex (MAC) prophylactic medications in 643 patients enrolled in a trial of MAC prophylaxis. By week 56 of the study follow-up, 42% of the patients reported nonadherence to MAC prophylaxis, whereas one-quarter of the patients reported nonadherence to potent antiretroviral regimens. Nonadherence to both MAC prophylaxis and antiretroviral therapy was associated with higher human immunodeficiency virus (HIV) type 1 RNA levels and a significant increase in the risk of developing an AIDS-defining complication or death. Predictors of nonadherence are presented. These results underscore the clinical significance of adherence to HIV therapy and may be helpful in designing interventions to optimize the management of HIV by improving adherence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据